Furthermore, the use of current therapeutic strategies for podocytopathies, such as renin-angiotensin-aldosterone system blockade and glucocorticoids, also inhibited NF-κB signaling to a degree,55, , –58 highlighting the potential significance of calibrated NF-κB inhibition in human glomerular diseases. The gene discussed is NFKB1; the disease is glomerular disorder.